This month Surgeon General Jerome Adams issued an advisory that touted the lifesaving potential of naloxone, an opioid antagonist that reverses potentially fatal overdoses. He called for wider distribution of naloxone to opioid users, their relatives, and their close associates.
While that move is commendable, the surgeon general pulled his punches. He can and should go further by pressing the Food and Drug Administration to reclassify naloxone as an over-the-counter drug, writes Jeffrey Singer, a Phoenix physician and senior fellow at the Cato Institute.
from Hit & Run https://ift.tt/2FmHVoy
via IFTTT